What Happened
- The United States agreed to lower tariffs on Indian goods from 50% to 18% as part of the India-US interim bilateral trade framework announced in February 2026.
- The 50% figure comprised two layers: a 25% "reciprocal tariff" and an additional 25% penalty imposed for India's purchase of Russian oil; both were removed under the deal.
- India's new 18% rate is more favourable than Vietnam (which faces higher tariffs) but less favourable than China's negotiated rate — reflecting each country's strategic and economic weight in US calculations.
- India agreed to eliminate or reduce tariffs on all US industrial goods and a wide range of agricultural products — including dried distillers' grains, tree nuts, fresh fruit, soybean oil, and wine.
- The deal also includes an Indian commitment to purchase over $500 billion in US products over five years, address non-tariff barriers in ICT and medical devices, and align import licensing norms with international standards.
Static Topic Bridges
Reciprocal Tariffs and Bilateral Trade Policy
A "reciprocal tariff" is a duty designed to match the rate that a trading partner charges on a country's exports — the theory being that trade should be balanced on equal terms. This departs from the WTO-based principle of Most Favoured Nation (MFN) treatment (GATT Article I), which requires uniform tariff treatment across all trading partners. The US "reciprocal tariff" framework invoked during the Trump administration was justified under emergency trade statutes (IEEPA — International Emergency Economic Powers Act, 1977) rather than through standard WTO trade remedy mechanisms. The Supreme Court ultimately struck down IEEPA-based tariffs in February 2026, prompting the administration to pivot to Section 122 of the Trade Act of 1974.
- GATT Article I (MFN): Any tariff advantage given to one country must be extended to all WTO members
- IEEPA (1977): Allows the US president to regulate international economic transactions during a declared national emergency — courts ruled this does not extend to tariffs
- Section 232 (Trade Expansion Act, 1962): Authorises tariffs on national security grounds (used for steel/aluminium)
- Section 301 (Trade Act, 1974): Allows tariffs to counter unfair trade practices of specific countries
Connection to this news: The 18% reciprocal tariff on Indian goods reflects a bilaterally negotiated rate rather than a standard MFN tariff — a trade policy construct that UPSC tests in questions on trade disputes, WTO consistency, and US trade statutes.
India's Export Basket and Sectoral Vulnerabilities
India's exports to the US span several key sectors — pharmaceuticals (generic drugs), gems and diamonds, textiles, engineering goods, chemicals, leather, and software services. The composition of India's export basket determines which sectors are most exposed to tariff increases and which gain the most from preferential agreements. Under the interim deal, the US agreed to zero tariffs on generic pharmaceuticals, gems and diamonds, and aircraft parts — sectors of high Indian competitiveness. Tariffs of 18% apply to textiles, leather, plastic, organic chemicals, home décor, and machinery.
- India's goods exports to the US: approximately $77 billion (2024)
- Pharmaceuticals: India supplies ~40% of generic drugs consumed in the US; zero tariff retained under deal
- Gems and diamonds: India processes approximately 90% of the world's rough diamonds
- Textiles and apparel: Faces 18% tariff — competes with Bangladesh, Vietnam, and China in US market
- Software services: Not covered by goods tariffs (covered under services trade separately)
Connection to this news: The differential tariff structure (zero on pharma, 18% on textiles) reflects the US leveraging tariff policy to address trade deficits while protecting critical supply chains — a pattern UPSC tests in questions on India's trade structure and comparative advantage.
Non-Tariff Barriers (NTBs) and Market Access
Non-tariff barriers (NTBs) are trade restrictions that are not in the form of explicit customs duties. They include import licensing, sanitary and phytosanitary (SPS) standards, technical barriers to trade (TBT), quotas, and procedural delays. The WTO Agreement on Technical Barriers to Trade (TBT Agreement) and the SPS Agreement govern how countries can use standards and regulations without disguising them as trade barriers. India's import licensing requirements for ICT goods and regulatory divergence in medical devices were specifically identified as NTBs in the India-US interim agreement.
- WTO TBT Agreement: Encourages use of international standards; requires equivalence assessment for other standards
- WTO SPS Agreement: Permits sanitary restrictions based on scientific evidence and international standards (Codex Alimentarius, OIE, IPPC)
- India to determine within six months whether US-developed or international standards are acceptable for US exports
- India to address NTBs in medical devices and ICT import licensing as part of the deal commitments
Connection to this news: The NTB commitments in the India-US deal are as significant as tariff changes — they determine effective market access and are frequently tested in UPSC questions on WTO dispute mechanisms and trade in services/goods.
Key Facts & Data
- US tariff on Indian goods: reduced from 50% to 18%
- Previous tariff breakdown: 25% reciprocal + 25% Russia oil penalty = 50%
- Zero tariff agreed on: generic pharmaceuticals, gems and diamonds, aircraft parts
- India's goods exports to the US: ~$77 billion (2024)
- India's pharmaceutical export share to US: ~40% of generic drug market
- India's diamond processing share: ~90% of global rough diamond processing
- India's total purchase commitment: over $500 billion in US goods over 5 years
- WTO MFN principle: GATT Article I
- IEEPA enacted: 1977; struck down by Supreme Court for tariff use: February 2026